Synopsis

Source of validity: Traditional
Rating (out of 5): 2

Grindelia, commonly known as gumweed, has a long history of traditional use for respiratory conditions, including spastic (or convulsive) coughs. Indigenous peoples of North America and later European settlers used Grindelia species as a remedy for bronchial irritation, asthma, and persistent coughs. The plant contains resinous compounds, flavonoids, and saponins, which are thought to contribute to its expectorant and mild antispasmodic effects. Traditional herbal texts and pharmacopeias from the 19th and early 20th centuries document its use for soothing irritated mucous membranes and reducing bronchial spasm, making it a common ingredient in cough syrups of that era.

However, while these uses are well-recorded in ethnobotanical and early medical literature, modern clinical trials or robust pharmacological studies specifically validating Grindelia for spastic cough are limited. There are some in vitro and animal studies showing mild relaxant effects on smooth muscle and anti-inflammatory properties, but these do not constitute strong scientific evidence for efficacy in humans. As such, the justification for its use in spastic cough is primarily traditional, with only weak supportive evidence from preclinical research.

More about Grindelia
More about Cough (spastic)

Other ingredients used for Cough (spastic)

Other health conditions supported by Grindelia

Products containing Grindelia